Czasopismo Journal of Contemporary Brachytherapy 2013

Ekkasit Tharavichitkul, Somsak Wanwilairat, Anirut Watcharawipha, Damrongsak Tippanya, Rungtip Jayasvasti, Somvilai Chakrabandhu, Pitchayaponne Klunklin, Wimrak Onchan, Razvan Galalae, Imjai Chitapanarux

J Contemp Brachytherapy 2013; 5, 4: 236-239

DOI: https://doi.org/10.5114/jcb.2013.38781

Streszczenie Treść artykułu

Original paper
New ¹²⁵I brachytherapy source IsoSeed I25.S17plus: Monte Carlo dosimetry simulation and comparison to sources of similar design

Evaggelos Pantelis, Panagiotis Papagiannis, Giorgos Anagnostopoulos, Dimos Baltas

J Contemp Brachytherapy 2013; 5, 4: 240-249

DOI: https://doi.org/10.5114/jcb.2013.39631

Streszczenie Treść artykułu

Original paper
Dosimetric impacts of applicator displacements and applicator reconstruction-uncertainties on 3D image-guided brachytherapy for cervical cancer

Joshua Schindel, Winson Zhang, Sudershan K. Bhatia, Wenqing Sun, Yusung Kim

J Contemp Brachytherapy 2013; 5, 4: 250-257

DOI: https://doi.org/10.5114/jcb.2013.39453

Streszczenie Treść artykułu

Case report
Bilateral episcleral brachytherapy in simultaneous choroidal melanoma and circumscribed hemangioma

María Encarnación Correa-Pérez, María Antonia Saornil, Ciro García-Álvarez, Francisco Lopez-Lara Martín, Jesus María Frutos-Baraja

J Contemp Brachytherapy 2013; 5, 4: 258-262

DOI: https://doi.org/10.5114/jcb.2013.38523

Streszczenie Treść artykułu

Calendar of events

DOI: https://doi.org/10.5114/jcb.2013.39904

Treść artykułu

Original paper
Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes

Original paper
Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysis

Original paper
Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatment

Original paper
Three-dimensional dosimetric considerations from different point A definitions in cervical cancer low-dose-rate brachytherapy

Original paper
The importance of the implant quality in APBI – Gliwice experience. Dosimetric evaluation

Original paper
Head and neck ¹⁹²Ir HDR-brachytherapy dosimetry using a grid-based Boltzmann solver

Original paper
The effect of central shielding in the dose reporting for cervical cancer in EQD2 era

Original paper
New ¹²⁵I brachytherapy source IsoSeed I25.S17plus: Monte Carlo dosimetry simulation and comparison to sources of similar design

Original paper
Dosimetric impacts of applicator displacements and applicator reconstruction-uncertainties on 3D image-guided brachytherapy for cervical cancer

Case report
Bilateral episcleral brachytherapy in simultaneous choroidal melanoma and circumscribed hemangioma

Calendar of events

Coverage in

Indexed in

Integrated with

Editorial Policies

Original paperProstate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes

Original paperProstate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysis

Original paperTime to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatment

Original paperThree-dimensional dosimetric considerations from different point A definitions in cervical cancer low-dose-rate brachytherapy

Original paperThe importance of the implant quality in APBI – Gliwice experience. Dosimetric evaluation

Original paperHead and neck 192Ir HDR-brachytherapy dosimetry using a grid-based Boltzmann solver

Original paperThe effect of central shielding in the dose reporting for cervical cancer in EQD2 era

Original paperNew 125I brachytherapy source IsoSeed I25.S17plus: Monte Carlo dosimetry simulation and comparison to sources of similar design

Original paperDosimetric impacts of applicator displacements and applicator reconstruction-uncertainties on 3D image-guided brachytherapy for cervical cancer

Case reportBilateral episcleral brachytherapy in simultaneous choroidal melanoma and circumscribed hemangioma

Calendar of events

Coverage in

Indexed in

Integrated with

Editorial Policies

Original paper
Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes

Original paper
Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysis

Original paper
Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatment

Original paper
Three-dimensional dosimetric considerations from different point A definitions in cervical cancer low-dose-rate brachytherapy

Original paper
The importance of the implant quality in APBI – Gliwice experience. Dosimetric evaluation

Original paper
Head and neck ¹⁹²Ir HDR-brachytherapy dosimetry using a grid-based Boltzmann solver

Original paper
The effect of central shielding in the dose reporting for cervical cancer in EQD2 era

Original paper
New ¹²⁵I brachytherapy source IsoSeed I25.S17plus: Monte Carlo dosimetry simulation and comparison to sources of similar design

Original paper
Dosimetric impacts of applicator displacements and applicator reconstruction-uncertainties on 3D image-guided brachytherapy for cervical cancer

Case report
Bilateral episcleral brachytherapy in simultaneous choroidal melanoma and circumscribed hemangioma